Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension.
dc.contributor.author | Pinto, Lancelot M | |
dc.contributor.author | Morekar, Sunil | |
dc.contributor.author | Mahashur, Ashok A | |
dc.date.accessioned | 2012-05-30T07:59:36Z | |
dc.date.available | 2012-05-30T07:59:36Z | |
dc.date.issued | 2009-10 | |
dc.description.abstract | A 75-year-old female was commenced on sildenafil for the treatment of pulmonary arterial hypertension (PAH) secondary to chronic obstructive pulmonary disease (COPD). She reported blurring of vision within 72 hours after starting treatment and was found to have a central retinal vein occlusion (CRVO). Such an occurrence is the second case reported to date, and we review the possible mechanisms and literature on the subject. | en_US |
dc.identifier.citation | Pinto Lancelot M, Morekar Sunil, Mahashur Ashok A. Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension. The Indian Journal of Chest Diseases and Allied Sciences, 2009 Oct; 51(4): 249-252. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/138756 | |
dc.language.iso | en | en_US |
dc.source.uri | https://medind.nic.in/iae/t09/i4/iaet09i4p249.pdf | en_US |
dc.subject | Sildenafil | en_US |
dc.subject | Central retinal vein occlusion | en_US |
dc.subject.mesh | 3',5'-Cyclic-GMP Phosphodiesterases --antagonists & inhibitors | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Diagnosis, Differential | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Hypertension, Pulmonary --drug therapy | |
dc.subject.mesh | Phosphodiesterase Inhibitors --adverse effects | |
dc.subject.mesh | Phosphodiesterase Inhibitors --therapeutic use | |
dc.subject.mesh | Piperazines --adverse effects | |
dc.subject.mesh | Piperazines --therapeutic use | |
dc.subject.mesh | Purines --adverse effects | |
dc.subject.mesh | Purines --therapeutic use | |
dc.subject.mesh | Retinal Vein Occlusion --chemically induced | |
dc.subject.mesh | Retinal Vein Occlusion --diagnosis | |
dc.subject.mesh | Sulfones --adverse effects | |
dc.subject.mesh | Sulfones --therapeutic use | |
dc.title | Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension. | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijcdas2009v51n4p249.pdf
- Size:
- 92.5 KB
- Format:
- Adobe Portable Document Format
- Description:
- Journal article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: